Stocks to sell

Private company space wars seemed like science fiction just 10 or 20 years ago, but are now coming to fruition as multiple competitors gear up for the new race for space dominance. Jeff Bezos’s Blue Origin and Elon Musk’s SpaceX are among the leaders in the field. But one of the early innovators in this

Value investors are at a loss to explain the performance of Alibaba (NYSE:BABA) stock. Holding BABA stock in the hopes that the shares can return to their 52-week high may prove to be unprofitable. Source: BigTunaOnline / Shutterstock.com That’s because China’s government is introducing stricter regulations in many sectors. So despite paying a $2.75 billion

Although I’m a car enthusiast, I’m not in love with Nio (NYSE:NIO) stock. In fact, I’ve repeatedly suggested that investors avoid it in the past. Source: xiaorui / Shutterstock.com In 2020 I wrote the article “Nio Stock Has Skyrocketed in 2020, But High Risks Remain” using the Nasdaq Dozen method to analyze the company, I focused

A month ago I wrote that Uber (NYSE:UBER) was likely to fall 20% from $49.07 on July 9, and not rise over 42% like other analysts were saying. Since then, UBER stock has dropped over 17% to below $40 and is still falling. Source: NYCStock / Shutterstock.com I suspect that, given another lousy loss-making quarter by

A week after a disappointing earnings report sent shares of ContextLogic (NASDAQ:WISH) plunging almost 21%, WISH stock hovers just above its 12-month low of $6.14 a share. Source: sdx15 / Shutterstock.com At one point on Aug. 13, shares were down 28.9% from the previous day’s close. The hits kept coming, as one influential analyst said

For the quarter ending May 1, 2021, GameStop (NYSE:GME) was able to reduce its total store count by 12% year-over-year (YoY), according to its first-quarter earnings release. As a result, the company’s losses fell from $165.1 million or $2.65 per share last year to just $66.8 million or $1.01 per share this quarter. This is

The U.S. infrastructure bill has been passed by the Senate. Will this initiative give ChargePoint (NYSE:CHPT) stock a boost? I wouldn’t really count on it. Sure, EV charging companies, including ChargePoint, stand to benefit greatly from this bill. The legislation could give early-stage companies in this industry a shot in the arm as they grow into

I have always wondered about why the memesters decided they liked Clover Health (NASDAQ:CLOV) stock. Source: Shutterstock Maybe it was the short squeeze, which came after Hindenburg Research issued a February report calling the business broken. Maybe it was Chamath Palihapitiya, whom I have likened to Prof. Harold Hill of The Music Man. (Full disclosure:

Exela Technologies (NASDAQ:XELA) is a Texas company that sells itself as a leader in business process automation. The XELA stock price is down 8.6% in the last six months. Source: Alextype/Shutterstock.com The current company is the result of a 2017 tie-up of three companies which now suffers from crushing debts. Exela is still around thanks to

“The pill that moves the needle.” This is the statement highlighted on Vaxart’s (NASDAQ:VXRT) website, and it is written to make a bold impression. Recently, the company has been in the spotlight for its Covid-19 vaccine that is notably in pill form. Its inoculation isn’t ready yet, but some investors have already picked up shares

It hasn’t been a fun ride for Workhorse (NASDAQ:WHKS) stock. Source: rblfmr / Shutterstock.com In fact, most start-up EV, low-quality special purpose acquisition companies (SPACs) and high-growth stocks have struggled over the past few months. In the case of WKHS stock, shares remain 76% below the all-time high set in February. Unfortunately for Workhorse, earnings aren’t

Clover Health Investments (NASDAQ:CLOV) recently reported second quarter revenue and earnings on Aug 11. The numbers showed a huge gain in revenue but an equally huge increase in its losses. This does not bode well for CLOV stock. Source: Shutterstock Additionally, Clover significantly raised its total 2021 revenue outlook from $820 million at the midpoint last quarter

Contrary to the belief of many commentators, I think that the outlook of Carnival Corporation (NYSE:CCL) stock has improved in recent weeks. Source: Ruth Peterkin / Shutterstock.com Despite the negative impact of the Delta variant of the novel coronavirus, other, positive factors or Carnival, are, for now, outweighing the latest outbreak. Still, I believe that

Talk of Clover Health (NASDAQ:CLOV) stock being a great short-squeeze play is making the rounds once again. Source: Shutterstock So, should you buy into the insuretech play now at around $8.50 per share, in anticipation of it zooming back to $20 per share and beyond? Not so fast. It may still be one of the

When Clover Health (NASDAQ:CLOV) tested multiple bottoms from March to May, it set up a technical June rally next. Hindsight is 20/20 and does not make money. Speculators now know the CLOV stock spike from $8 to $28.85 in June would not last. Source: Shutterstock Bears are not done betting against Clover. The short float

Senseonics Holdings (NYSEAMERICAN:SENS) develops medical technology, including “continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa.” The company’s product line includes implantable CGM systems that go under the user’s skin and a removable, rechargeable transmitter that works with an app made by the company. SENS

Ever since Nano Dimension (NASDAQ:NNDM) peaked in Feb. 2021 and trended lower, Meta Materials (NASDAQ:MMAT) stock followed. Source: BLAGORODEZ / Shutterstock.com On Aug. 5, Meta Materials announced an indirect acquisition of Nanotech Security for CAD 90.8 million. Meta, whose technology platform delivers highly functional and sustainable materials, wants Nanotech for its authentication and brand protection

Marin Software (NASDAQ:MRIN), which makes enterprise software for the advertising industry, cratered over the last month. I think it is likely to still drop further. MRIN stock closed at $14.45 on July 12 when I wrote that it was likely to drop much further. At the close on Aug. 12, it was at $5.67 and

Seemingly out of nowhere, presidential and mayoral candidate Andrew Yang brought to the mainstream several ideas that absolutely needed to be talked about, one of them being data as the current century’s gold or oil. Since data is so valuable, it can theoretically fund multiple initiatives. For Palantir Technologies (NYSE:PLTR), that sounds just about right.

I have written two articles about Ocugen (NASDAQ:OCGN) in the past and I must say that if I had to summarize OCGN stock in two words, they would be irrational exuberance. Source: shutterstock.com/PhotobyTawat As of August 9, 2021, the company has a market valuation of $1.61 billion with zero revenue for 2019 and 2018. Yahoo!